Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Six Months of British Cancer Research Organization’s Genetic Data Decoded in One Month by Smartphone Gamers

By LabMedica International staff writers
Posted on 23 Mar 2014
In just one month, “citizen scientists” have studied DNA data that would have taken a scientist six months to analyze by eye by playing a new smartphone game Play to Cure: Genes in Space. More...


If this amount of DNA was stretched out, it would stretch across 65 km. Amazingly, this is a distance equivalent to the length of more than 80 times the height of the Burj Khalifa in Dubai, the world’s tallest building.

These figures follow the February 2014 launch of the playing Cancer Research UK’s (London, UK) novel game, which global gamers of all ages can play on their smartphones and simultaneously analyze gene data. Cancer Research UK’s scientists must interpret huge amounts of information to find cancer-causing genetic defects in develop new targeted therapies for patients. However, the human eye is required to locate patterns in the data--computers are not effective enough. Furthermore, it would take scientists a long time to do this manually—sidetracking their time from other vital research.

But the collective power of the sheer numbers of gamers worldwide have sped this up, and will increase accuracy with many pairs of eyes examining each stretch of DNA. In just one month, there have been 1.5 million classifications through the game from players in almost every country in world. Furthermore, citizen scientists have collectively devoted more than 53,000 hours—six and a half years—playing the game and analyzed approximately 50% of the data from the first research project.

Hannah Keartland, Cancer Research UK's citizen science lead, said, “We’re astounded by this fantastic support from citizen scientists across the world which goes to show—you don’t need to wear a lab coat to be a hero. “It’s crucial we don’t stop here because the more people who play in their spare moments, the quicker we’ll make a difference. There never again needs to be such a thing as a boring queue. It’s still early days but we believe the collective force of global gamers could have a massive impact and speed up our life-saving research.”

Prof. Carlos Caldas, senior group leader at the Cancer Research UK Cambridge Institute, University of Cambridge (UK), said, “We’re incredibly grateful to everyone who is giving their spare moments to help us analyze genetic data. We’re working hard to develop better drugs, improve the diagnosis of cancer patients and understand why some treatments work and others won’t—to spare unpleasant side effects. Computers can’t analyze our research data with 100% accuracy—we need the human eye for greater precision. It can take us years to decode the huge amounts of data generated by research. But with everyone’s help the boost to our work could be enormous.”

The game is available to download now for free for anyone with an Android or Apple Smartphone.

Related Links:

Cancer Research UK 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.